London South East Logo | UK Share Price information



Register
Login:
Share:
Email Facebook Twitter




Premaitha Share Price (NIPT)



Share Price Information for Premaitha (NIPT)


Share Price: 4.50Bid: 4.25Ask: 4.75Change: 0.00 (0.00%)No Movement on Premaitha
Spread: 0.50Spread as %: 11.76%Open: 4.50High: 4.50Low: 4.50Yesterday’s Close: 4.50

Premaitha Health Plc Ord 0.1P

Premaitha is listed in the FTSE AIM All-Share
Premaitha is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
4.50

Share Price SpacerBid
4.25

Share Price SpacerAsk
4.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
26,729

Share Price SpacerOpen
4.50

Share Price SpacerHigh
4.50

Share Price SpacerLow
4.50

Share Price SpacerClose
4.50

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 321.22m £14.45m 20,000

52 Week High 13.88 52 Week High Date 6-MAR-2017
52 Week Low 4.13 52 Week Low Date 22-NOV-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
3 26,729 0 -1.500 -3.00 0.00 0.00


London South East Users info for Premaitha




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Jan-18
12:24:28
4.377
1,960
Sell* 
4.25
4.75
85.79
Trade Type:
Ordinary

18-Jan-18
11:41:00
4.377
2,460
Sell* 
4.25
4.75
107.67
Trade Type:
Ordinary

18-Jan-18
09:44:05
4.425
22,309
Sell* 
4.25
4.75
987.17
Trade Type:
Ordinary




View more Premaitha trades >>

Directors Deals for Premaitha (NIPT)
Trade DateActionNotifierPriceCurrencyAmountHolding
17-Dec-15Buy
Trade Notifier Information for Premaitha Health
Barry Kenneth Hextall held the position of CFO at Premaitha Health at the time of this trade.
 Barry Kenneth Hextall
18.03GBX180,736332498
02-Nov-15Notification of Holding
Trade Notifier Information for Premaitha Health
William Denman held the position of Chief Medical Officer at Premaitha Health at the time of this trade.
 William Denman
00250000
02-Jul-15Placing
Trade Notifier Information for Premaitha Health
Barry Kenneth Hextall held the position of CFO at Premaitha Health at the time of this trade.
 Barry Kenneth Hextall
20GBX150,000151762
View more Premaitha directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Wed 23:45bakkyRE: Sorry chaps4.50No Opinion
France will just follow Germany as usual and throw it out, that's why they have not bothered with France imo!
Wed 23:10Steve67RE: Sorry chaps4.50No Opinion
Well nobody knows ... and that’s why we’re sitting on a PSR of about 2 ....

If you’re so downbeat and actually long here, why not sell up and move on?
Wed 22:55brainsparkRE: Sorry chaps4.50No Opinion
EU is currently 30% in revenue terms.
Who is to say llumina will now not start Litigation in France very soon?
Wed 20:32bakkyRE: Sorry chaps4.50No Opinion
meanwhile in that time UK is only 5% or less of global revenue!?
Wed 19:29brainsparkRE: Sorry chaps4.50No Opinion
Illumina are setting pretty. If this goes to appeal, with very little chance of success, the share price will stay this low for the whole of 2018 or maybe even lower. Sub 4p anyone?
Wed 18:47bakkyEu Comm4.50No Opinion
I reckon they have a better chance with the anti-trust as it will be a lot easier to prove I guess, well if you take into account the GOSH debacle which I hope will come back to bite Illumina.I believe there are other instances out there too where Illumina have been a bit naughty regards their practices.

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Premaitha (NIPT) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.